The management of the hospitalized ulcerative colitis patient: the medical-surgical conundrum

Curr Opin Gastroenterol. 2020 Jul;36(4):265-276. doi: 10.1097/MOG.0000000000000637.

Abstract

Purpose of review: In this review article, we address emerging evidence for the medical and surgical treatment of the hospitalized patient with ulcerative colitis.

Recent findings: Ulcerative colitis is a chronic inflammatory disease involving the colon and rectum. About one-fifth of patients will be hospitalized from ulcerative colitis, and about 20-30%, experiencing an acute flare will undergo colectomy. Because of the significant clinical consequences, patients hospitalized need prompt evaluation for potential complications, stratification of disease severity, and a multidisciplinary team approach to therapy, which involves both the gastroenterologist and surgeon. Although corticosteroids remain first-line therapy, second-line medical rescue options, primarily infliximab or cyclosporine, are considered within 3-5 days of presentation. In conjunction, an early surgical consultation to present the possibility of a staged proctocolectomy as one of the therapeutic options is equally important.

Summary: A coordinated multidisciplinary, individualized approach to treatment, involving the patient preferences throughout the process, is optimal in providing patient-centered effective care.

Publication types

  • Review

MeSH terms

  • Colectomy
  • Colitis, Ulcerative* / drug therapy
  • Colitis, Ulcerative* / surgery
  • Cyclosporine / therapeutic use
  • Humans
  • Infliximab / therapeutic use
  • Proctocolectomy, Restorative*

Substances

  • Cyclosporine
  • Infliximab